Cargando…
Utilization of Glycosaminoglycans/Proteoglycans as Carriers for Targeted Therapy Delivery
The outcome of patients with cancer has improved significantly in the past decade with the incorporation of drugs targeting cell surface adhesive receptors, receptor tyrosine kinases, and modulation of several molecules of extracellular matrices (ECMs), the complex composite of collagens, glycoprote...
Autores principales: | Misra, Suniti, Hascall, Vincent C., Atanelishvili, Ilia, Moreno Rodriguez, Ricardo, Markwald, Roger R., Ghatak, Shibnath |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4581573/ https://www.ncbi.nlm.nih.gov/pubmed/26448753 http://dx.doi.org/10.1155/2015/537560 |
Ejemplares similares
-
Roles of Proteoglycans and Glycosaminoglycans in Wound Healing and Fibrosis
por: Ghatak, Shibnath, et al.
Publicado: (2015) -
Stromal Hyaluronan Interaction with Epithelial CD44 Variants Promotes Prostate Cancer Invasiveness by Augmenting Expression and Function of Hepatocyte Growth Factor and Androgen Receptor
por: Ghatak, Shibnath, et al.
Publicado: (2010) -
Interactions between Hyaluronan and Its Receptors (CD44, RHAMM) Regulate the Activities of Inflammation and Cancer
por: Misra, Suniti, et al.
Publicado: (2015) -
FOLFOX Therapy Induces Feedback Upregulation of CD44v6 through YB-1 to Maintain Stemness in Colon Initiating Cells
por: Ghatak, Shibnath, et al.
Publicado: (2021) -
Interplay Between Chemotherapy-Activated Cancer Associated Fibroblasts and Cancer Initiating Cells Expressing CD44v6 Promotes Colon Cancer Resistance
por: Ghatak, Shibnath, et al.
Publicado: (2022)